Regulation of Dendritic Cell Function in Inflammation

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Said, André ^a   Weindl, Günther ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; CELL FUNCTION; CELL SUBPOPULATION; CYTOKINE RELEASE; DENDRITIC CELL; DERMIS; EPIDERMIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; PSORIASIS; REVIEW; ANIMAL; DERMATITIS; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

AUTACOID; CYTOKINE;

ANIMALS; CYTOKINES; DENDRITIC CELLS; DERMATITIS; HUMANS; IMMUNOMODULATION; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 84937019797     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/743169     Document Type: Review

References (191)

1. R. M. Steinman, "Dendritic cells: understanding immunogenicity," European Journal of Immunology, vol. 37, supplement 1, pp. S53-S60, 2007.
2. J. Banchereau and R. M. Steinman, "Dendritic cells and the control of immunity," Nature, vol. 392, no. 6673, pp. 245-252, 1998.
3. C. Y. J. Chung, D. Ysebaert, Z. N. Berneman, and N. Cools, "Dendritic cells: cellular mediators for immunological tolerance," Clinical and Developmental Immunology, vol. 2013, Article ID 972865, 8 pages, 2013.
4. J. Mbongue, D. Nicholas, A. Firek, and W. Langridge, "The role of dendritic cells in tissue-specific autoimmunity," Journal of Immunology Research, vol. 2014, Article ID 857143, 17 pages, 2014.
5. E. Segura, M. Touzot, A. Bohineust et al., "Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation," Immunity, vol. 38, no. 2, pp. 336-348, 2013.
6. C. Vestergaard, H. Just, J. Baumgartner Nielsen, K. Thestrup-Pedersen, and M. Deleuran, "Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis," Acta Dermato-Venereologica, vol. 84, no. 5, pp. 353-358, 2004.
7. G. G. Krueger, R. A. Daynes, and M. Emam, "Biology of langerhans cells: selective migration of langerhans cells into allogeneic and xenogeneic grafts on nude mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 6, pp. 1650-1654, 1983.
8. B. Berman, V. L. Chen, D. S. France, W. I. Dotz, and G. Petroni, "Anatomical mapping of epidermal Langerhans cell densities in adults," British Journal of Dermatology, vol. 109, no. 5, pp. 553-558, 1983.
9. + dendritic cells," Journal of Experimental Medicine, vol. 204, no. 13, pp. 3147-3156, 2007.
10. + dendritic cells survey the skin in the steady state," The Journal of Experimental Medicine, vol. 204, no. 13, pp. 3133-3146, 2007.
11. L. F. Poulin, S. Henri, B. de Bovis, E. Devilard, A. Kissenpfennig, and B. Malissen, "The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells," Journal of Experimental Medicine, vol. 204, no. 13, pp. 3119-3131, 2007.
12. R. van de Ven, M. F. C. M. van den Hout, J. J. Lindenberg et al., "Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to Tcell activation," Blood, vol. 118, no. 9, pp. 2502-2510, 2011.
13. + dendritic cells," Journal of Leukocyte Biology, vol. 97, no. 4, pp. 627-634, 2015.
14. V. Peña-Cruz, S. Ito, C. C. Dascher, M. B. Brenner, and M. Sugita, "Epidermal Langerhans cells efficiently mediate CD1adependent presentation of microbial lipid antigens to T cells," Journal of Investigative Dermatology, vol. 121, no. 3, pp. 517-521, 2003.
15. R. P. Moseley, J. I. Brown, J. Auld et al., "An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytes," The Journal of Pathology, vol. 181, no. 4, pp. 419-425, 1997.
16. M. J. Kleijmeer, V. M. J. Oorschot, and H. J. Geuze, "Human resident Langerhans cells display a lysosomal compartment enriched in MHC class II," Journal of Investigative Dermatology, vol. 103, no. 4, pp. 516-523, 1994.
17. A. M. G. van der Aar, R. M. R. Sylva-Steenland, J. D. Bos, M. L. Kapsenberg, E. C. de Jong, and M. B. M. Teunissen, "Cutting edge: Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition," Journal of Immunology, vol. 178, no. 4, pp. 1986-1990, 2007.
18. V. Flacher, M. Bouschbacher, E. Verronèse et al., "Human langerhans cells express a specific TLR profile and differentially respond to viruses and gram-positive bacteria," The Journal of Immunology, vol. 177, no. 11, pp. 7959-7967, 2006.
19. J. Takeuchi, E. Watari, E. Shinya et al., "Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells," Biochemical and Biophysical Research Communications, vol. 306, no. 3, pp. 674-679, 2003.
20. E. Klechevsky, M. Liu, R. Morita et al., "Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines," Human Immunology, vol. 70, no. 5, pp. 281-288, 2009.
21. C. N. Renn, D. J. Sanchez, M. T. Ochoa et al., "TLR activation of langerhans cell-like dendritic cells triggers an antiviral immune response," The Journal of Immunology, vol. 177, no. 1, pp. 298-305, 2006.
22. + T cell responses," The Journal of Immunology, vol. 187, no. 7, pp. 3488-3492, 2011.
23. A. M. G. van der Aar, D. I. Picavet, F. J. Muller et al., "Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells," Journal of Investigative Dermatology, vol. 133, no. 5, pp. 1240-1249, 2013.
24. A. Said, S. Bock, G. Müller, and G. Weindl, "Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro," Immunology, vol. 144, no. 2, pp. 218-230, 2015.
25. A. Wollenberg, S. Kraft, D. Hanau, and T. Bieber, "Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema," Journal of Investigative Dermatology, vol. 106, no. 3, pp. 446-453, 1996.
26. M. Grewe, C. A. F. M. Bruijnzeel-Koomen, E. Schöpf et al., "A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis," Immunology Today, vol. 19, no. 8, pp. 359-361, 1998.
27. T. Bieber, "Atopic dermatitis," The New England Journal of Medicine, vol. 358, no. 14, pp. 1483-1494, 2008.
28. Y. Tokura, "Extrinsic and intrinsic types of atopic dermatitis," Journal of Dermatological Science, vol. 58, no. 1, pp. 1-7, 2010.
29. V. Soumelis, P. A. Reche, H. Kanzler et al., "Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP," Nature Immunology, vol. 3, no. 7, pp. 673-680, 2002.
30. Y. Urata, Y. Osuga, G. Izumi et al., "Interleukin-1β stimulates the secretion of thymic stromal lymphopoietin (TSLP) from endometrioma stromal cells: possible involvement of TSLP in endometriosis," Human Reproduction, vol. 27, no. 10, pp. 3028-3035, 2012.
31. M. J. Elder, A.Y. Ng, S. J. Webster, M. J. Bacon, J.H. Gaston, and J. C. Goodall, "Human dendritic cells produce thymic stromal lymphopoietin in response to pattern recognition receptor ligation and this secretion is augmented by endoplasmic reticulum stress," Arthritis & Rheumatism, vol. 65, supplement 10, p. 1147, 2013.
32. A. Boltjes and F. van Wijk, "Human dendritic cell functional specialization in steady-state and inflammation," Frontiers in Immunology, vol. 5, 2014.
33. G. K. Perera, P. di Meglio, and F. O. Nestle, "Psoriasis," Annual Review of Pathology:Mechanisms of Disease, vol. 7, pp. 385-422, 2012.
34. J. L. Jones, J. Berth-Jones, A. Fletcher, and P. E. Hutchinson, "Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis," Journal of Pathology, vol. 174, no. 2, pp. 77-82, 1994.
35. C. Albanesi, O. De Pità, and G. Girolomoni, "Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes," Clinics in Dermatology, vol. 25, no. 6, pp. 581-588, 2007.
36. M. Cumberbatch, M. Singh, R. J. Dearman, H. S. Young, I. Kimber, and C. E. M. Griffiths, "Impaired Langerhans cell migration in psoriasis," Journal of Experimental Medicine, vol. 203, no. 4, pp. 953-960, 2006.
37. E. Glitzner, A. Korosec, P. M. Brunner et al., "Specific roles for dendritic cell subsets during initiation and progression of psoriasis," EMBO Molecular Medicine, vol. 6, no. 10, pp. 1312-1327, 2014.
38. K. Seré, J.-H. Baek, J. Ober-Blöbaum et al., "Two distinct types of Langerhans cells populate the skin during steady state and inflammation," Immunity, vol. 37, no. 5, pp. 905-916, 2012.
39. N. Romani, C.H. Tripp, and P. Stoitzner, "Langerhans cells come in waves," Immunity, vol. 37, no. 5, pp. 766-768, 2012.
40. F. Geissmann, C. Prost, J.-P. Monnet, M. Dy, N. Brousse, and O. Hermine, "Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells," Journal of Experimental Medicine, vol. 187, no. 6, pp. 961-966, 1998.
41. + blood dendritic cells have Langerhans cell potential," Blood, vol. 125, no. 3, pp. 470-473, 2015.
42. N. Romani and J. W. Young, "Langerhans cells: straight from blood to skin?" Blood, vol. 125, no. 3, pp. 420-422, 2015.
43. + nonlymphoid dendritic cells," Immunity, vol. 37, no. 1, pp. 60-73, 2012.
44. + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens," Journal of Experimental Medicine, vol. 207, no. 6, pp. 1247-1260, 2010.
45. F.O. Nestle, X.-G. Zheng, C. B. Thompson, L. A. Turka, and B. J. Nickoloff, "Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets," Journal of Immunology, vol. 151, no. 11, pp. 6535-6545, 1993.
46. + macrophages," The Journal of Clinical Investigation, vol. 117, no. 9, pp. 2517-2525, 2007.
47. + dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation," Journal of Experimental Medicine, vol. 209, no. 5, pp. 935-945, 2012.
48. + dendritic cells," Journal of Experimental Medicine, vol. 207, no. 6, pp. 1261-1271, 2010.
49. + dendritic cells," The Journal of Experimental Medicine, vol. 207, no. 6, pp. 1283-1292, 2010.
50. + dendritic cells," Journal of Experimental Medicine, vol. 207, no. 6, pp. 1273-1281, 2010.
51. M. Haniffa, M. Collin, and F. Ginhoux, "Ontogeny and functional specialization of dendritic cells in human and mouse," Advances in Immunology, vol. 120, pp. 1-49, 2013.
52. + cells are a transient population of monocyte-derived macrophages," Immunity, vol. 41, no. 3, pp. 465-477, 2014.
53. D. K. Fogg, C. Sibon, C. Miled et al., "A clonogenic bone harrow progenitor specific formacrophages and dendritic cells," Science, vol. 311, no. 5757, pp. 83-87, 2006.
54. K. Liu, G. D. Victora, T. A. Schwickert et al., "In vivo analysis of dendritic cell development and homeostasis," Science, vol. 324, no. 5925, pp. 392-397, 2009.
55. V. Bigley, M. Haniffa, S. Doulatov et al., "The human syndrome of dendritic cell, monocyte, B and NKlymphoid deficiency," The Journal of Experimental Medicine, vol. 208, no. 2, pp. 227-234, 2011.
56. S. Hambleton, S. Salem, J. Bustamante et al., "IRF8 mutations and human dendritic-cellimmunodeficiency," The New England Journal of Medicine, vol. 365, no. 2, pp. 127-138, 2011.
57. C. Hémont, A. Neel, M. Heslan, C. Braudeau, and R. Josien, "Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness," Journal of Leukocyte Biology, vol. 93, no. 4, pp. 599-609, 2013.
58. T.-P. V. Manh, Y. Alexandre, T. Baranek, K. Crozat, and M. Dalod, "Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation," European Journal of Immunology, vol. 43, no. 7, pp. 1706-1715, 2013.
59. B. León, M. López-Bravo, and C. Ardavín, "Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania," Immunity, vol. 26, no. 4, pp. 519-531, 2007.
60. M. Haniffa, M. Gunawan, and L. Jardine, "Human skin dendritic cells in health and disease," Journal of Dermatological Science, vol. 77, no. 2, pp. 85-92, 2015.
61. F. Sallusto and A. Lanzavecchia, "Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha," Journal of Experimental Medicine, vol. 179, no. 4, pp. 1109-1118, 1994.
62. F. Chapuis, M. Rosenzwajg, M. Yagello, M. Ekman, P. Biberfeld, and J. C. Gluckman, "Differentiation of human dendritic cells frommonocytes in vitro," European Journal of Immunology, vol. 27, no. 2, pp. 431-441, 1997.
63. D. A. Hume, N. Mabbott, S. Raza, and T. C. Freeman, "Can DCs be distinguished from macrophages by molecular signatures?" Nature Immunology, vol. 14, no. 3, pp. 187-189, 2013.
64. N.A. Mabbott, J.K. Baillie, H. Brown, T. C. Freeman, and D.A. Hume, "An expression atlas of human primary cells: inference of gene function from coexpression networks," BMC Genomics, vol. 14, no. 1, article 632, 2013.
65. A.N. Harman, C. R. Bye, N. Nasr et al., "Identificationof lineage relationships and novel markers of blood and skin human dendritic cells," Journal of Immunology, vol. 190, no. 1, pp. 66-79, 2013.
66. N. Novak, T. Bieber, and S. Kraft, "Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis," Current Allergy and Asthma Reports, vol. 4, no. 4, pp. 263-269, 2004.
67. F. O. Nestle, C. Conrad, A. Tun-Kyi et al., "Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production," Journal of Experimental Medicine, vol. 202, no. 1, pp. 135-143, 2005.
68. M. Cella, D. Jarrossay, F. Faccheth et al., "Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon," Nature Medicine, vol. 5, no. 8, pp. 919-923, 1999.
69. M. Gilliet, C. Conrad, M. Geiges et al., "Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors," Archives of Dermatology, vol. 140, no. 12, pp. 1490-1495, 2004.
70. C. Albanesi, C. Scarponi, S. Pallotta et al., "Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment," The Journal of Experimental Medicine, vol. 206, no. 1, pp. 249-258, 2009.
71. J. Skrzeczyńska-Moncznik, K. Wawro, A. Stefańska et al., "Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin," Biochemical and Biophysical Research Communications, vol. 380, no. 2, pp. 323-327, 2009.
72. R. Cerio, C.E.M. Griffiths, K.D. Cooper, B. J. Nickoloff, and J. T. Headington, "Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin," British Journal of Dermatology, vol. 121, no. 4, pp. 421-431, 1989.
73. L.C. Zaba, J. Fuentes-Duculan, N. J. Eungdamrong et al., "Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells," The Journal of Investigative Dermatology, vol. 129, no. 1, pp. 79-88, 2009.
74. A. Hänsel, C. Günther, J. Ingwersen et al., "Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strongTh17/Th1 T-cell responses," Journal of Allergy and Clinical Immunology, vol. 127, no. 3, pp. 787-794, 2011.
75. J. Cros, N. Cagnard, K. Woollard et al., "Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors," Immunity, vol. 33, no. 3, pp. 375-386, 2010.
76. M. A. Lowes, F. Chamian, M. V. Abello et al., "Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 52, pp. 19057-19062, 2005.
77. N. V. Serbina, T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E.G. Pamer, "TNF/iNOS-producing dendritic cellsmediate innate immune defense against bacterial infection," Immunity, vol. 19, no. 1, pp. 59-70, 2003.
78. D. Wilsmann-Theis, S. Koch, C. Mindnich et al., "Generation and functional analysis of human TNF-α/iNOS-producing dendritic cells (Tip-DC)," Allergy, vol. 68, no. 7, pp. 890-898, 2013.
79. T. Bosschaerts, M. Guilliams, B. Stijlemans et al., "Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-γ and MyD88 signaling," PLoS Pathogens, vol. 6, no. 8, Article ID e1001045, 2010.
80. J. Mirkovitch, A. König, K.-S. Sauter et al., "Single-cell analysis divides bovine monocyte-derived dendritic cells into subsets expressing either high or low levels of inducible nitric oxide synthase," Veterinary Immunology and Immunopathology, vol. 114, no. 1-2, pp. 1-14, 2006.
81. C.-C. Chu, P. DiMeglio, and F. O. Nestle, "Harnessing dendritic cells in inflammatory skin diseases," Seminars in Immunology, vol. 23, no. 1, pp. 28-41, 2011.
82. T. B. H. Geijtenbeek and S. I. Gringhuis, "Signalling through C-type lectin receptors: shaping immune responses," Nature Reviews Immunology, vol. 9, no. 7, pp. 465-479, 2009.
83. S. I. Gringhuis, J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T. H. Geijtenbeek, "C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB," Immunity, vol. 26, no. 5, pp. 605-616, 2007.
84. + dendritic cells secrete high levels of IL-12 and potently prime cytotoxic Tcell responses," Blood, vol. 122, no. 6, pp. 932-942, 2013.
85. G. Y. Chen and G. Nuñez, "Sterile inflammation: sensing and reacting to damage," Nature Reviews Immunology, vol. 10, no. 12, pp. 826-837, 2010.
86. S. Janssens and R. Beyaert, "A universal role for MyD88 in TLR/IL-1R-mediated signaling," Trends in Biochemical Sciences, vol. 27, no. 9, pp. 474-482, 2002.
87. H. Hsu, J. Xiong, and D. V. Goeddel, "The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation," Cell, vol. 81, no. 4, pp. 495-504, 1995.
88. R. M. Steinman and H. Hemmi, "Dendritic cells: translating innate to adaptive immunity," Current Topics in Microbiology and Immunology, vol. 311, pp. 17-58, 2006.
89. K. B. Narayanan and H. H. Park, "Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways," Apoptosis, vol. 20, no. 2, pp. 196-209, 2015.
90. A. K. Wesa and A. Galy, "IL-1 beta induces dendritic cells to produce IL-12," International Immunology, vol. 13, no. 8, pp. 1053-1061, 2001.
91. + T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells," The Journal of Immunology, vol. 193, no. 12, pp. 6135-6143, 2014.
92. + hemopoietic progenitors," Journal of Immunology, vol. 157, no. 4, pp. 1499-1507, 1996.
93. H. Strobl, C. Bello-Fernandez, E. Riedl et al., "flt3 ligand in cooperation with transforming growth factor-β1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serumfree conditions," Blood, vol. 90, no. 4, pp. 1425-1434, 1997.
94. T. A. Borkowski, J. J. Letterio, C. L. Mackall et al., "A role for TGFβ1 in langerhans cell biology: further characterization of the epidermal Langerhans cell defect in TGFβ1 null mice," The Journal of Clinical Investigation, vol. 100, no. 3, pp. 575-581, 1997.
95. H17 cell differentiation by antagonizing RORγt function," Nature, vol. 453, no. 7192, pp. 236-240, 2008.
96. K. Matsumoto, K. Hashimoto, M. Hashiro, H. Yoshimasa, and K. Yoshikawa, "Modulation of growth and differentiation in normal human keratinocytes by transforming growth factorbeta," Journal of Cellular Physiology, vol. 145, no. 1, pp. 95-101, 1990.
97. A. Bobr, B. Z. Igyarto, K.M. Haley, M. O. Li, R.A. Flavell, and D. H. Kaplan, "Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 26, pp. 10492-10497, 2012.
98. F. Geissmann, P. Revy, A. Regnault et al., "TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells," Journal of Immunology, vol. 162, no. 8, pp. 4567-4575, 1999.
99. T. Ohtani, M. Mizuashi, S. Nakagawa et al., "TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation," Immunology, vol. 126, no. 4, pp. 485-499, 2009.
100. J. Mohammed, A. J. Gunderson, H.-H. Khong, R. D. Koubek, M. C. Udey, and A. B. Glick, "TGFβ1 overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity," Journal of Investigative Dermatology, vol. 133, no. 1, pp. 135-143, 2013.
101. L. Ohl, M. Mohaupt, N. Czeloth et al., "CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions," Immunity, vol. 21, no. 2, pp. 279-288, 2004.
102. K. Ouwehand, S. J. A. M. Santegoets, D. P. Bruynzeel, R. J. Scheper, T. D. de Gruijl, and S. Gibbs, "CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis," European Journal of Immunology, vol. 38, no. 11, pp. 3050-3059, 2008.
103. K. Kabashima, N. Shiraishi, K. Sugita et al., "CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells," The American Journal of Pathology, vol. 171, no. 4, pp. 1249-1257, 2007.
104. E. J. Villablanca and J. R. Mora, "A two-step model for Langerhans cell migration to skin-draining LN," European Journal of Immunology, vol. 38, no. 11, pp. 2975-2980, 2008.
105. K. Sato, H. Kawasaki, H. Nagayama et al., "TGF-β1 reciprocally controls chemotaxis of human peripheral blood monocytederived dendritic cells via chemokine receptors," The Journal of Immunology, vol. 164, no. 5, pp. 2285-2295, 2000.
106. K. Ouwehand, S. W. Spiekstra, T. Waaijman et al., "CCL5 and CCL20 mediate immigration of Langerhans cells into the epidermis of full thickness human skin equivalents," European Journal of Cell Biology, vol. 91, no. 10, pp. 765-773, 2012.
107. M. Cumberbatch, I. Fielding, and I. Kimber, "Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-α," Immunology, vol. 81, no. 3, pp. 395-401, 1994.
108. A. H. Enk, V. L. Angeloni, M. C. Udey, and S. I. Katz, "An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin," The Journal of Immunology, vol. 150, no. 9, pp. 3698-3704, 1993.
109. P. Stoitzner, M. Zanella, U. Ortner et al., "Migration of langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-α and IL-1β," Journal of Leukocyte Biology, vol. 66, no. 3, pp. 462-470, 1999.
110. + dermal dendritic cells," Immunity, vol. 29, no. 3, pp. 497-510, 2008.
111. + DCs controls CTL priming," Blood, vol. 119, no. 24, pp. 5742-5749, 2012.
112. M. N. Artyomov, A. Munk, L. Gorvel et al., "Modular expression analysis reveals functional conservation between human langerhans cells and mouse cross-priming dendritic cells," The Journal of Experimental Medicine, vol. 212, no. 5, pp. 743-757, 2015.
113. + dendritic cells in human and mouse control mucosal IL-17 cytokine responses," Immunity, vol. 38, no. 5, pp. 970-983, 2013.
114. S. S. Jensen and M. Gad, "Differential induction of inflammatory cytokines by dendritic cells treated with novel TLRagonist and cytokine based cocktails: targeting dendritic cells in autoimmunity," Journal of Inflammation, vol. 7, article 37, 2010.
115. R. M. Steinman and J. Banchereau, "Taking dendritic cells into medicine," Nature, vol. 449, no. 7161, pp. 419-426, 2007.
116. + T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine," The Journal of Experimental Medicine, vol. 203, no. 3, pp. 607-617, 2006.
117. P. Stoitzner, S. Schaffenrath, C. H. Tripp et al., "Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors," Experimental Dermatology, vol. 23, no. 12, pp. 909-915, 2014.
118. R. M. Steinman, A. Granelli-Piperno, M. Pope et al., "The interaction of immunodeficiency viruses with dendritic cells," Current Topics in Microbiology and Immunology, vol. 276, pp. 1-30, 2003.
119. E. B. Lindblad, "Aluminium compounds for use in vaccines," Immunology and Cell Biology, vol. 82, no. 5, pp. 497-505, 2004.
120. X. Chen, G. Kositratna, C. Zhou, D. Manstein, and M. X. Wu, "Micro-fractional epidermal powder delivery for improved skin vaccination," Journal of Controlled Release, vol. 192, pp. 310-316, 2014.
121. R. R. Shah, D. T. O'Hagan, M. M. Amiji, and L. A. Brito, "The impact of size on particulate vaccine adjuvants," Nanomedicine, vol. 9, no. 17, pp. 2671-2681, 2014.
122. N. Riteau, L. Baron, B. Villeret et al., "ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation," Cell Death and Disease, vol. 3, no. 10, article e403, 2012.
123. M. V. Fernandez, E. A. Miller, and N. Bhardwaj, "Activation and measurement of NLRP3 inflammasome activity using IL-1β in human monocyte-derived dendritic cells," Journal of Visualized Experiments, no. 87, 2014.
124. L. Broderick, D. deNardo, B. S. Franklin, H.M. Hoffman, and E. Latz, "The inflammasomes and autoinflammatory syndromes," Annual Review of Pathology: Mechanisms of Disease, vol. 10, no. 1, pp. 395-424, 2015.
125. H. Fujita, A. Shemer, M. Suárez-Fariñas et al., "Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets," Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 574-582.e12, 2011.
126. L. M. Johnson-Huang, N. S. McNutt, J. G. Krueger, and M. A. Lowes, "Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases," Journal of Clinical Immunology, vol. 29, no. 3, pp. 247-256, 2009.
127. M. Diani, G. Altomare, and E. Reali, "T cell responses in psoriasis and psoriatic arthritis," Autoimmunity Reviews, vol. 14, no. 4, pp. 286-292, 2015.
128. D. Ganguly, G. Chamilos, R. Lande et al., "Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8," Journal of Experimental Medicine, vol. 206, no. 9, pp. 1983-1994, 2009.
129. R. Lande, J. Gregorio, V. Facchinetti et al., "Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide," Nature, vol. 449, no. 7162, pp. 564-569, 2007.
130. neg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 26, pp. 10723-10728, 2013.
131. M. Kristensen, C. Q. Chu, D. J. Eedy, M. Feldmann, F. M. Brennan, and S. M. Breathnach, "Localization of tumour necrosis factor-α (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor," Clinical and Experimental Immunology, vol. 94, no. 2, pp. 354-362, 1993.
132. C. E. M. Griffiths, J. J. Voorhees, and B. J. Nickoloff, "Characterization of intercullular adhesion molecule-1 and HLADR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor," Journal of the American Academy of Dermatology, vol. 20, no. 4, pp. 617-629, 1989.
133. C. G. Larsen, A. O. Anderson, J. J. Oppenheim, and K. Matsushima, "Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor," Immunology, vol. 68, no. 1, pp. 31-36, 1989.
134. M. Partridge, D. Chantry, M. Turner, and M. Feldmann, "Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines," Journal of Investigative Dermatology, vol. 96, no. 5, pp. 771-776, 1991.
135. F. O. Nestle, L. A. Turka, and B. J. Nickoloff, "Characterization of dermal dendritic cells in psoriasis: autostimulation of T lymphocytes and induction of Th1 type cytokines," Journal of Clinical Investigation, vol. 94, no. 1, pp. 202-209, 1994.
136. C. L. Leonardi, J. L. Powers, R. T. Matheson et al., "Etanercept as monotherapy in patients with psoriasis," The New England Journal of Medicine, vol. 349, no. 21, pp. 2014-2022, 2003.
137. A. B. Gottlieb, "Infliximab for psoriasis," Journal of the American Academy of Dermatology, vol. 49, no. 2, pp. S112-S117, 2003.
138. E. Donetti, L. Cornaghi, A. Gualerzi, F. W. B. Preis, and F. Prignano, "An innovative three-dimensional model of normal human skin to study the proinflammatory psoriatic effects of tumor necrosis factor-alpha and interleukin-17," Cytokine, vol. 68, no. 1, pp. 1-8, 2014.
139. N. J. Wilson, K. Boniface, J. R. Chan et al., "Development, cytokine profile and function of human interleukin 17-producing helper T cells," Nature Immunology, vol. 8, no. 9, pp. 950-957, 2007.
140. K. Bosniface, W. M. Blumenschein, K. Brovont-Porth et al., "Human Th17 cells comprise heterogeneous subsets including IFN-γ-producing cells with distinct properties from the Th1 lineage," Journal of Immunology, vol. 185, no. 1, pp. 679-687, 2010.
141. H-17 responses," Nature Immunology, vol. 9, no. 6, pp. 650-657, 2008.
142. K. Ghoreschi, P. Thomas, S. Breit et al., "Interleukin-4 therapyof psoriasis induces Th2 responses and improves human autoimmune disease," Nature Medicine, vol. 9, no. 1, pp. 40-46, 2003.
143. H17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 7, pp. 2163-2168, 2015.
144. S. Eyerich, K. Eyerich, D. Pennino et al., "Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling," Journal of Clinical Investigation, vol. 119, no. 12, pp. 3573-3585, 2009.
145. E. G. Harper, C. Guo, H. Rizzo et al., "Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis," Journal of Investigative Dermatology, vol. 129, no. 9, pp. 2175-2183, 2009.
146. M. A. Lowes, T. Kikuchi, J. Fuentes-Duculan et al., "Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells," Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1207-1211, 2008.
147. + T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines," Journal of Leukocyte Biology, vol. 86, no. 2, pp. 435-443, 2009.
148. C. L. Roark, P. L. Simonian, A. P. Fontenot, W. K. Born, and R. L. O'Brien, "γδ T cells: an important source of IL-17," Current Opinion in Immunology, vol. 20, no. 3, pp. 353-357, 2008.
149. A. V. Rachitskaya, A. M. Hansen, R. Horai et al., "Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion," Journal of Immunology, vol. 180, no. 8, pp. 5167-5171, 2008.
150. C. T. Weaver, R. D. Hatton, P. R. Mangan, and L. E. Harrington, "IL-17 family cytokines and the expanding diversity of effector T cell lineages," Annual Review of Immunology, vol. 25, pp. 821-852, 2007.
151. N. V. Valeyev, C. Hundhausen, Y. Umezawa et al., "A systems model for immune cell interactions unravels the mechanism of inflammation in human skin," PLoS Computational Biology, vol. 6, no. 12, Article ID e1001024, 2010.
152. M. Bando, Y. Hiroshima, M. Kataoka et al., "Interleukin-1α regulates antimicrobial peptide expression in human keratinocytes," Immunology & Cell Biology, vol. 85, no. 7, pp. 532-537, 2007.
153. K. Kabashima, "New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity," Journal of Dermatological Science, vol. 70, no. 1, pp. 3-11, 2013.
154. G. Stingl and D. Maurer, "IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells," International Archives of Allergy and Immunology, vol. 113, no. 1-3, pp. 24-29, 1997.
155. G. C. Mudde, F. C. Van Reijsen, G. J. Boland, G. C. de Gast, P. L. B. Bruijnzeel, and C. A. F. M. Bruijnzeel-Koomen, "Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE," Immunology, vol. 69, no. 3, pp. 335-341, 1990.
156. N. Novak, T. Bieber, and D. Y. M. Leung, "Immunemechanisms leading to atopic dermatitis," The Journal of Allergy & Clinical Immunology, vol. 112, no. 6, pp. S128-S139, 2003.
157. N. Novak, C. Tepel, S. Koch, K. Brix, T. Bieber, and S. Kraft, "Evidence for a differential expression of the Fc∈RIγ chain in dendritic cells of atopic and nonatopic donors," Journal of Clinical Investigation, vol. 111, no. 7, pp. 1047-1056, 2003.
158. D. Y. M. Leung, "Newinsights into atopic dermatitis: role of skin barrier and immune dysregulation," Allergology International, vol. 62, no. 2, pp. 151-161, 2013.
159. M. M. Neis, B. Peters, A. Dreuw et al., "Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis," Journal of Allergy and Clinical Immunology, vol. 118, no. 4, pp. 930-937, 2006.
160. C. A. Akdis and K. Blaser, "Regulation of specific immune responses by chemical and structural modifications of allergens," International Archives of Allergy and Immunology, vol. 121, no. 4, pp. 261-269, 2000.
161. S. I. Bogiatzi, I. Fernandez, J.-C. Bichet et al., "Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes," The Journal of Immunology, vol. 178, no. 6, pp. 3373-3377, 2007.
162. H.-C. Lee and S. F. Ziegler, "Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκB," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 914-919, 2007.
163. Z. Allakhverdi, M. R. Comeau, H. K. Jessup et al., "Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells," The Journal of Experimental Medicine, vol. 204, no. 2, pp. 253-258, 2007.
164. T. Ito, Y.-H. Wang, O. Duramad et al., "TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand," Journal of Experimental Medicine, vol. 202, no. 9, pp. 1213-1223, 2005.
165. N. Fujimoto, H. Ishida, I. Nakamura, K. Ogasawara, and Y. Itoh, "Quantities of interleukin-12p40 inmature CD8α negative dendritic cells correlate with strength of TCR signal and determine Thcell development," Microbiology and Immunology, vol. 47, no. 12, pp. 1017-1024, 2003.
166. J. Wang and F. Xing, "Human TSLP-educated DCs," Cellular and Molecular Immunology, vol. 5, no. 2, pp. 99-106, 2008.
167. E. Guttman-Yassky, M. A. Lowes, J. Fuentes-Duculan et al., "Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis," The Journal of Allergy & Clinical Immunology, vol. 119, no. 5, pp. 1210-1217, 2007.
168. T. Bieber, N. Novak, N. Herrman, and S. Koch, "Role of dendritic cells in atopic dermatitis: an update," Clinical Reviews in Allergy and Immunology, vol. 41, no. 3, pp. 254-258, 2011.
169. E. Gros, C. Bussmann, T. Bieber, I. Förster, and N. Novak, "Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis," Journal of Allergy and Clinical Immunology, vol. 124, no. 4, pp. 753-760, 2009.
170. K. E. Nograles, L. C. Zaba, A. Shemer et al., "IL-22-producing 'T22' T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells," Journal of Allergy and Clinical Immunology, vol. 123, no. 6, pp. 1244.e2-1252.e2, 2009.
171. H22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis," The Journal of Allergy & Clinical Immunology, vol. 130, no. 6, pp. 1344-1354, 2012.
172. H. Fujita, K. E. Nograles, T. Kikuchi, J. Gonzalez, J. A. Carucci, and J. G. Krueger, "Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 51, pp. 21795-21800, 2009.
173. P. C. M. Res, G. Piskin, O. J. de Boer et al., "Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis," PLoS ONE, vol. 5, no. 11, Article ID e14108, 2010.
174. J.-C. Renauld, "Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators," Nature Reviews Immunology, vol. 3, no. 8, pp. 667-676, 2003.
175. B. S. Kim, "Innate lymphoid cells in the skin," Journal of Investigative Dermatology, vol. 135, no. 3, pp. 673-678, 2015.
176. S. Mashiko, S. Bouguermouh, M. Rubio, N. Baba, R. Bissonnette, and M. Sarfati, "Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis," Journal of Allergy and Clinical Immunology, 2015.
177. S. Benoit, A. Toksoy, M. Ahlmann et al., "Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis," British Journal of Dermatology, vol. 155, no. 1, pp. 62-66, 2006.
178. H. Martinsson, M. Yhr, and C. Enerbäck, "Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation," Experimental Dermatology, vol. 14, no. 3, pp. 161-168, 2005.
179. J. Goyette and C. L. Geczy, "Inflammation-associated S100 proteins: new mechanisms that regulate function," Amino Acids, vol. 41, no. 4, pp. 821-842, 2011.
180. B. Sampson, M. K. Fagerhol, C. Sunderkötter et al., "Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism," The Lancet, vol. 360, no. 9347, pp. 1742-1745, 2002.
181. C. Albanesi, H. R. Fairchild, S. Madonna et al., "IL-4 and IL-13 negatively regulate TNF-β- and IFN-γ-induced β-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3," Journal of Immunology, vol. 179, no. 2, pp. 984-992, 2007.
182. I. Nomura, E. Goleva, M. D. Howell et al., "Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes," The Journal of Immunology, vol. 171, no. 6, pp. 3262-3269, 2003.
183. P. Y. Ong, T. Ohtake, C. Brandt et al., "Endogenous antimicrobial peptides and skin infections in atopic dermatitis," The New England Journal of Medicine, vol. 347, no. 15, pp. 1151-1160, 2002.
184. K. Boniface, F.-X. Bernard, M. Garcia, A. L. Gurney, J.-C. Lecron, and F. Morel, "IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes," Journal of Immunology, vol. 174, no. 6, pp. 3695-3702, 2005.
185. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat, "IL-22 increases the innate immunity of tissues," Immunity, vol. 21, no. 2, pp. 241-254, 2004.
186. R. Gläser, U. Meyer-Hoffert, J. Harder et al., "The antimicrobial protein psoriasin (S100a7) is upregulated in atopic dermatitis and after experimental skin barrier disruption," Journal of Investigative Dermatology, vol. 129, no. 3, pp. 641-649, 2009.
187. K. Reginald, K. Westritschnig, T. Werfel et al., "Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients," Clinical & Experimental Allergy, vol. 41, no. 3, pp. 357-369, 2011.
188. H. Hasannejad, R. Takahashi, M. Kimishima, K. Hayakawa, and T. Shiohara, "Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis," Journal of Allergy and Clinical Immunology, vol. 120, no. 1, pp. 69-75, 2007.
189. M. Niebuhr, C. Lutat, S. Sigel, and T. Werfel, "Impaired TLR-2 expression and TLR-2-mediated cytokine secretion inmacrophages frompatients with atopic dermatitis," Allergy, vol. 64, no. 11, pp. 1580-1587, 2009.
190. D. Terhorst, B.N. Kalali, S. Weidinger et al., "Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands," Clinical and Experimental Allergy, vol. 37, no. 3, pp. 381-390, 2007.
191. T. Volz, Y. Skabytska, E. Guenova et al., "Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells," Journal of Investigative Dermatology, vol. 134, no. 1, pp. 96-104, 2014.